Search

Your search keyword '"James, Stefan"' showing total 22 results
Start Over Author "James, Stefan" Journal journal of the american heart association
22 results on '"James, Stefan"'

1. Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage Study.

Author

Bergström, Göran, Hagberg, Eva, Björnson, Elias, Adiels, Martin, Bonander, Carl, Strömberg, Ulf, Andersson, Jonas, Brunström, Mattias, Carlhäll, Carl-Johan, Engström, Gunnar, Erlinge, David, Goncalves, Isabel, Gummesson, Anders, Hagström, Emil, Hjelmgren, Ola, James, Stefan, Janzon, Magnus, Jonasson, Lena, Lind, Lars, and Magnusson, Martin

Published
2024
Full Text
View/download PDF

3. On the Natural History of Coronary Artery Disease: A Longitudinal Nationwide Serial Angiography Study

Author

Mohammad, Moman A., primary, Stone, Gregg W., additional, Koul, Sasha, additional, Olivecrona, Göran K., additional, Bergman, Sofia, additional, Persson, Jonas, additional, Engstrøm, Thomas, additional, Fröbert, Ole, additional, Jernberg, Tomas, additional, Omerovic, Elmir, additional, James, Stefan, additional, Bergström, Göran, additional, and Erlinge, David, additional

Published
2022
Full Text
View/download PDF

4. Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors ‐ a VALIDATE‐SWEDEHEART Substudy

Author

Bergman, Sofia, primary, Mohammad, Moman A., additional, James, Stefan K., additional, Angerås, Oskar, additional, Wagner, Henrik, additional, Jensen, Jens, additional, Scherstén, Fredrik, additional, Fröbert, Ole, additional, Koul, Sasha, additional, and Erlinge, David, additional

Published
2021
Full Text
View/download PDF

5. Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials

Author

Mahmoodi, Bakhtawar K., primary, Eriksson, Niclas, additional, Ross, Stephanie, additional, Claassens, Daniel M. F., additional, Asselbergs, Folkert W., additional, Meijer, Karina, additional, Siegbahn, Agneta, additional, James, Stefan, additional, Pare, Guillaume, additional, Wallentin, Lars, additional, and ten Berg, Jurriën M., additional

Published
2021
Full Text
View/download PDF

6. Short‐ and Long‐Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry

Author

Redfors, Björn, primary, Jha, Sandeep, additional, Thorleifsson, Sigurdur, additional, Jernberg, Tomas, additional, Angerås, Oskar, additional, Frobert, Ole, additional, Petursson, Petur, additional, Tornvall, Per, additional, Sarno, Giovanna, additional, Ekenbäck, Christina, additional, Ravn‐Fisher, Annika, additional, Y‐Hassan, Shams, additional, Lyon, Alexander R., additional, James, Stefan, additional, Erlinge, David, additional, and Omerovic, Elmir, additional

Published
2021
Full Text
View/download PDF

8. Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Author

Gregersen, Ida, primary, Michelsen, Annika E., additional, Lunde, Ngoc Nguyen, additional, Åkerblom, Axel, additional, Lakic, Tatevik G., additional, Skjelland, Mona, additional, Ryeng Skagen, Karolina, additional, Becker, Richard C., additional, Lindbäck, Johan, additional, Himmelmann, Anders, additional, Solberg, Rigmor, additional, Johansen, Harald T., additional, James, Stefan K., additional, Siegbahn, Agneta, additional, Storey, Robert F., additional, Kontny, Frederic, additional, Aukrust, Pål, additional, Ueland, Thor, additional, Wallentin, Lars, additional, and Halvorsen, Bente, additional

Published
2020
Full Text
View/download PDF

10. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y 12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

Author

Franchi, Francesco, James, Stefan, Ghukasyan, Tatevik, Budaj, Andrzej J., Cornel, Jan H., Katus, Hugo A., Keltai, Matyas, Kontny, Frederic, Lewis, Basil S., Storey, Robert F., Himmelmann, Anders, Wallentin, Lars, Angiolillo, Dominick J., Parkhomenko, Alexander Nikolaevich, Oto, Ali, Skene, Allan, Budaj, Andrzej, Freij, Anneli, Santoso, Anwar, Armando, A, Meier, Bernhard, Yu, Cheuk Man, Cannon, Christopher P., Zambahari, Dato Seri Robaayah, Wu, Delon Wu, Ardissino, Diego, Raev, Dimitar, Kremastinos, Dimitrios, Weaver, Douglas, Paolasso, Ernesto, Giannitsis, Evangelos, Verheugt, Freek, Maurer, Gerald, Katus, Hugo, Emanuelsson, Hakan, Horrow, Jay, Bassand, Jean-Pierre, Spinar, Jindrich, Morais, Joao, Lopez Sendon, Jose, Nicolau, Jose, Seung, Ki-Bae, Teik, Lim Soo, Heras, Magda, Claeys, Marc J., Sabatine, Marc, Vintila, Marius, Ruda, Mikhail, Thorsen, Mona, Kleiman, Neil, Babilonia, Noe, Commerford, Patrick, Gurbel, Paul, Aylward, Phil, Steg, Philippe Gabriel, Theroux, Pierre, Sritara, Piyamitr, Pais, Prem, Becker, Richard, Lassila, Riitta, Harrington, Robert A., Gao, Runlin, Husted, Steen, Duris, Tibor, Chapichadze, Zaza, HUS Comprehensive Cancer Center, University Management, Department of Oncology, and PLATO Investigators

Subjects
Male, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Comorbidity, 030204 cardiovascular system & hematology, urologic and male genital diseases, FUNCTION PROFILES, RESPONSIVENESS, Electrocardiography, 0302 clinical medicine, Risk Factors, Coronary Heart Disease, ARTERY-DISEASE, Medicine, Cardiac and Cardiovascular Systems, 030212 general & internal medicine, Myocardial infarction, Stroke, Original Research, Kardiologi, Absolute risk reduction, Diabetes, Type 2, DUAL ANTIPLATELET THERAPY, Middle Aged, Prognosis, Clopidogrel, female genital diseases and pregnancy complications, 3. Good health, Survival Rate, diabetes mellitus, Female, Cardiology and Cardiovascular Medicine, Ticagrelor, medicine.drug, Platelets, RENAL-FUNCTION, medicine.medical_specialty, Acute coronary syndrome, ANTITHROMBOTIC THERAPY, INHIBITION, acute coronary syndrome, ticagrelor, 03 medical and health sciences, Internal medicine, Diabetes mellitus, Humans, Renal Insufficiency, Chronic, Aged, Retrospective Studies, Pharmacology, clopidogrel, Dose-Response Relationship, Drug, business.industry, Thrombosis, medicine.disease, United States, REACTIVITY, 3121 General medicine, internal medicine and other clinical medicine, Purinergic P2Y Receptor Antagonists, Human medicine, business, Acute Coronary Syndromes, Platelet Aggregation Inhibitors, chronic kidney disease, Follow-Up Studies, Kidney disease
Abstract

Background There are limited data on how the combination of diabetes mellitus ( DM ) and chronic kidney disease ( CKD ) affects cardiovascular outcomes as well as response to different P2Y 12 receptor antagonists, which represented the aim of the present investigation. Methods and Results In this post hoc analysis of the PLATO (Platelet Inhibition and Patient Outcomes) trial, which randomized acute coronary syndrome patients to ticagrelor versus clopidogrel, patients (n=15 108) with available DM and CKD status were classified into 4 groups: DM +/ CKD + (n=1058), DM +/ CKD − (n=2748), DM −/ CKD + (n=2160), and DM −/ CKD − (n=9142). The primary efficacy end point was a composite of cardiovascular death, myocardial infarction, or stroke at 12 months. The primary safety end point was PLATO major bleeding. DM +/ CKD + patients had a higher incidence of the primary end point compared with DM −/ CKD − patients (23.3% versus 7.1%; adjusted hazard ratio 2.22; 95% CI 1.88–2.63; P DM +/ CKD − and DM −/ CKD + had an intermediate risk profile. The same trend was shown for the individual components of the primary end point and for major bleeding. Compared with clopidogrel, ticagrelor reduced the incidence of the primary end point consistently across subgroups ( P ‐interaction=0.264), but with an increased absolute risk reduction in DM +/ CKD +. The effects on major bleeding were also consistent across subgroups ( P ‐interaction=0.288). Conclusions In acute coronary syndrome patients, a gradient of risk was observed according to the presence or absence of DM and CKD , with patients having both risk factors at the highest risk. Although the ischemic benefit of ticagrelor over clopidogrel was consistent in all subgroups, the absolute risk reduction was greatest in patients with both DM and CKD . Clinical Trial Registration URL : http://www.clinicatrials.gov . Unique identifier: NCT 00391872.

Published
2019

11. Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence‐Based Care in Heart Disease Evaluated According to Recommended Therapies)

Author

Varenhorst, Christoph, primary, Hasvold, Pål, additional, Johansson, Saga, additional, Janzon, Magnus, additional, Albertsson, Per, additional, Leosdottir, Margret, additional, Hambraeus, Kristina, additional, James, Stefan, additional, Jernberg, Tomas, additional, Svennblad, Bodil, additional, and Lagerqvist, Bo, additional

Published
2018
Full Text
View/download PDF

12. Impact of Thrombus Aspiration on Mortality, Stent Thrombosis, and Stroke in Patients With ST‐Segment–Elevation Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry

Author

Angerås, Oskar, primary, Haraldsson, Inger, additional, Redfors, Björn, additional, Fröbert, Ole, additional, Petursson, Petur, additional, Albertsson, Per, additional, Ioanes, Dan, additional, Odenstedt, Jacob, additional, Olsson, Hans, additional, Witt, Nils, additional, Rück, Andreas, additional, Millgård, Jonas, additional, Nilsson, Johan, additional, Persson, Jonas, additional, Söderbom, Måns, additional, Wedel, Hans, additional, Erlinge, David, additional, James, Stefan, additional, Råmunddal, Truls, additional, and Omerovic, Elmir, additional

Published
2018
Full Text
View/download PDF

14. Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding

Author

Lindholm, Daniel, primary, Hagström, Emil, additional, James, Stefan K., additional, Becker, Richard C., additional, Cannon, Christopher P., additional, Himmelmann, Anders, additional, Katus, Hugo A., additional, Maurer, Gerald, additional, López‐Sendón, José Luis, additional, Steg, Philippe Gabriel, additional, Storey, Robert F., additional, Siegbahn, Agneta, additional, and Wallentin, Lars, additional

Published
2017
Full Text
View/download PDF

16. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial.

Author

Franchi, Francesco, James, Stefan K., Lakic, Tatevik Ghukasyan, Budaj, Andrzej J., Cornel, Jan H., Katus, Hugo A., Keltai, Matyas, Kontny, Frederic, Lewis, Basil S., Storey, Robert F., Himmelmann, Anders, Wallentin, Lars, Angiolillo, Dominick J., Ghukasyan Lakic, Tatevik, and PLATO Investigators

Published
2019
Full Text
View/download PDF

18. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.

Author

Ueland, Thor, Åkerblom, Axel, Ghukasyan, Tatevik, Michelsen, Annika E., Aukrust, Pål, Becker, Richard C., Bertilsson, Maria, Himmelmann, Anders, James, Stefan K., Siegbahn, Agneta, Storey, Robert F., Kontny, Frederic, Wallentin, Lars, and the PLATO (Platelet Inhibition and Patient Outcomes) Trial Investigators

Published
2018
Full Text
View/download PDF

19. Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention

Author

Hess, Connie N., primary, Roe, Matthew T., additional, Clare, Robert M., additional, Chiswell, Karen, additional, Kelly, Joseph, additional, Tcheng, James E., additional, Hagstrom, Emil, additional, James, Stefan K., additional, Khouri, Michel G., additional, Hirsch, Bradford R., additional, Kong, David F., additional, Abernethy, Amy P., additional, and Krucoff, Mitchell W., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results